Reaction

Congenital Tricuspid Valve Incompetence reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 190 reports · 3 co-occurring drugs

As of the last recalculation, Congenital Tricuspid Valve Incompetence appears in 190 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is CEFUROXIME (PRR 101.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Cefuroxime10101.1101.2
Nicotine Polacrilex Mini1077.077.1
Nicotine Polarilex1077.077.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.